Literature DB >> 18353479

Genetic variation of hepatitis C virus in a cohort of injection heroin users in Wuhan, China.

Jin-Song Peng1, Xu Wang, Man-Qing Liu, Dun-Jin Zhou, Jie Gong, Han-Ming Xu, Jian-Ping Chen, Hong-Hao Zhu, Wang Zhou, Wen-Zhe Ho.   

Abstract

Since the majority of heroin abusers use injection as the primary route of admission, heroin abuse contributes significantly to the transmission of hepatitis C virus (HCV). We determined HCV infection and its genotype distribution among injection heroin users in Wuhan, the largest city in the central China. Eight hundred seventy-eight (84%) out of 1046 serum specimens from the injection drug users were positive for HCV antibody. Out of randomly selected 122 specimens positive for HCV antibody, seventy-eight (64%) had detectable HCV RNA with genotype 6a as the predominant strain (50%), followed by 3b (32.2%), 1a (8.1%), 1b (6.5%), and 3a (3.2%). HCV RNA levels in male heroin users were significantly higher (P=0.013) than those in the female subjects. Although there was no significant difference in HCV RNA levels among the specimens positive for HCV 6a and 1a/1b, the samples with 6a or 1a/1b contained higher levels of HCV RNA than the specimens positive for HCV 3b (P=0.019, P=0.012, respectively). These findings indicate that there is a high prevalence of HCV infection with genotypes 6a and 3b as predominated strains among injection heroin users in Wuhan, China.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18353479      PMCID: PMC2483840          DOI: 10.1016/j.virusres.2008.01.017

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  38 in total

1.  Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes.

Authors:  L Stuyver; W van Arnhem; A Wyseur; F Hernandez; E Delaporte; G Maertens
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

2.  Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C.

Authors:  A Matsumoto; E Tanaka; T Suzuki; H Ogata; K Kiyosawa
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

3.  Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level.

Authors:  G Yamada; M Takatani; F Kishi; M Takahashi; T Doi; T Tsuji; S Shin; M Tanno; M S Urdea; J A Kolberg
Journal:  Hepatology       Date:  1995-11       Impact factor: 17.425

4.  Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases.

Authors:  D L Thomas; R O Cannon; C N Shapiro; E W Hook; M J Alter; T C Quinn
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

5.  Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C.

Authors:  E Orito; M Mizokami; T Nakano; H Terashima; O Nojiri; K Sakakibara; M Mizuno; M Ogino; M Nakamura; Y Matsumoto
Journal:  J Med Virol       Date:  1994-12       Impact factor: 2.327

Review 6.  Management of hepatitis C.

Authors:  Marcus Teo; Peter Hayes
Journal:  Br Med Bull       Date:  2004-10-04       Impact factor: 4.291

7.  Quantitative branched DNA assay and genotyping for hepatitis C virus RNA in Chinese patients with acute and chronic hepatitis C.

Authors:  C Y Chan; S D Lee; S J Hwang; R H Lu; C L Lu; K J Lo
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

8.  Genotypic analysis of hepatitis C virus in American patients.

Authors:  K Mahaney; V Tedeschi; G Maertens; A M Di Bisceglie; J Vergalla; J H Hoofnagle; R Sallie
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

9.  Clinical significance of serum hepatitis C virus titers in patients with chronic type C hepatitis.

Authors:  J H Kao; M Y Lai; P J Chen; L H Hwang; W Chen; D S Chen
Journal:  Am J Gastroenterol       Date:  1996-03       Impact factor: 10.864

Review 10.  Correlates of hepatitis C virus infections among injection drug users.

Authors:  D L Thomas; D Vlahov; L Solomon; S Cohn; E Taylor; R Garfein; K E Nelson
Journal:  Medicine (Baltimore)       Date:  1995-07       Impact factor: 1.889

View more
  15 in total

Review 1.  Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6.

Authors:  Vasilios Papastergiou; Stylianos Karatapanis
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

2.  Migration patterns of hepatitis C virus in China characterized for five major subtypes based on samples from 411 volunteer blood donors from 17 provinces and municipalities.

Authors:  Ling Lu; Min Wang; Wenjie Xia; Linwei Tian; Ru Xu; Chunhua Li; Jingxing Wang; Xia Rong; Huaping Xiong; Ke Huang; Jieting Huang; Tatsunori Nakano; Phil Bennett; Yong Zhang; Linqi Zhang; Yongshui Fu
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

Review 3.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

4.  Assessment of HCV genotypes in Yunnan Province of Southwest China.

Authors:  Qiongfen Li; Yufeng Yao; Yunsong Shen; Danfeng Cao; Yalin Li; Shuqiong Zhang; Wei Cun; Mingbo Sun; Jiankun Yu; Li Shi; Shaozhong Dong
Journal:  Virus Genes       Date:  2016-12-23       Impact factor: 2.332

5.  Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china.

Authors:  Zehui Yan; Ke Fan; Yuming Wang; Yi Fan; Zhaoxia Tan; Guohong Deng
Journal:  Hepat Mon       Date:  2012-03-28       Impact factor: 0.660

6.  Exploratory social network analysis and gene sequencing in people who inject drugs infected with hepatitis C virus.

Authors:  Y Wang; X D Tan; C Zhou; W Zhou; J S Peng; Y S Ren; Z L Ni; B Liu; F Yang; X D Gao
Journal:  Epidemiol Infect       Date:  2016-07-13       Impact factor: 4.434

7.  New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors.

Authors:  Y Fu; Y Wang; W Xia; O G Pybus; W Qin; L Lu; K Nelson
Journal:  J Viral Hepat       Date:  2011-01       Impact factor: 3.728

8.  HCV subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in China.

Authors:  Chiyu Zhang; Nana Wu; Jun Liu; Qinjuan Ge; Yan Huang; Qian Ren; Qingchuan Feng; Guangli He
Journal:  PLoS One       Date:  2011-02-03       Impact factor: 3.240

9.  HCV 6a prevalence in Guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analyses.

Authors:  Yongshui Fu; Weibing Qin; Hong Cao; Ru Xu; Yi Tan; Teng Lu; Hongren Wang; Wangxia Tong; Xia Rong; Gang Li; Manqiong Yuan; Chunhua Li; Kenji Abe; Ling Lu; Guihua Chen
Journal:  PLoS One       Date:  2012-01-09       Impact factor: 3.240

10.  The current hepatitis C virus prevalence in China may have resulted mainly from an officially encouraged plasma campaign in the 1990s: a coalescence inference with genetic sequences.

Authors:  Ling Lu; Wangxia Tong; Lin Gu; Chunhua Li; Teng Lu; Kok Keng Tee; Guihua Chen
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.